Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vista BioMedical
Rochester, Minnesota, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Vista BioMedical has commercialized VPAATH, an AI-driven analytics platform identifying high-risk/high-utilization patients and predicting chronic disease and ER risk, as well as VistaSURE, a proprietary urinalysis device integrated with a mobile app. Both are being marketed to healthcare payers and providers, especially targeting health equity and chronic disease early risk screening[1][2].
- Therapeutic areas
- NephrologyCardiovascularOtherEndocrinology
- Modalities
- DeviceSoftware
- Industry
- Metabolite Diagnostics
02
Partnerships
University of Minnesota (exclusive technology license)
Beyond the preview
Go deeper on Vista BioMedical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vista BioMedical.